Improved understanding the specific role of miR-500a-3p in the activation of STAT3 signaling pathway and in the pathogenesis of hepatocelluar carcinoma facilitates the development of novel therapeutic methods in the treatment of hepatocellular carcinoma. This evidence concerns the gene STAT3 and hepatocellular carcinoma.